Clostridium difficile infection: clinical spectrum and approach to management (Q37970002)

26 August 2017

title

Clostridium difficile infection: clinical spectrum and approach to management (English)

1 reference

26 August 2017

main subject

Clostridium difficile

0 references

author name string

Chetana Vaishnavi

series ordinal

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

Indian Journal of Gastroenterology

26 August 2017

published in

1 reference

26 August 2017

volume

30

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

245-254

1 reference

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile: an emerging epidemic in nursing homes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

The potential for airborne dispersal of Clostridium difficile from symptomatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile toxin and faecal lactoferrin assays in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clinical and endoscopic findings in patients early in the course of clostridium difficile-associated pseudomembranous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Fulminant Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile associated infection, diarrhea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Incidence of Clostridium difficile infection in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Fulminant Clostridium difficile enteritis after proctocolectomy and ileal pouch-anal anastamosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Thinking beyond the colon-small bowel involvement in clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Rapidly progressive necrotizing fasciitis and gangrene due to Clostridium difficile: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile: an under-recognized cause of reactive arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Reactive arthritis due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Acute appendicitis in the setting of Clostridium difficile colitis: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

21 January 2018

Pseudomembranous colitis

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Established and potential risk factors for Clostridum difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

The burden of Clostridium difficile in surgical patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile: controversies and approaches to management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Invasive Saccharomyces infection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Prebiotics, probiotics, and dietary fiber in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile: new therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Nitazoxanide for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Fidaxomicin versus vancomycin for Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12664-011-0148-Y

Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay

21 January 2018

1 reference

12 December 2020

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea

1 reference

12 December 2020

[Feces culture successful therapy in Clostridium difficile diarrhea]

1 reference

12 December 2020

Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction.

1 reference

12 December 2020

Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis

1 reference

12 December 2020

Bacteremia due to Clostridium difficile--review of the literature

1 reference

12 December 2020

Clostridium difficile toxin assay in psoriatic patients

1 reference

12 December 2020

Clinical manifestation of Clostridium difficile enteritis in Calcutta

1 reference

12 December 2020

Arthritis in Pseudomembranous Colitis Associ Ated with an Antibody to Clostridium Difficile Toxin

1 reference

12 December 2020

Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature

1 reference

12 December 2020

Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients

1 reference

12 December 2020

Detection of Clostridium difficile toxin by an indigenously developed latex agglutination assay

1 reference

12 December 2020

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea

1 reference

12 December 2020

Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta

1 reference

12 December 2020

Reactive arthritis induced by Clostridium difficile

1 reference

12 December 2020

Clindamycin-associated colitis. A prospective study

1 reference

12 December 2020

Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee

1 reference

12 December 2020

Clostridium difficile in hospital patients

1 reference

12 December 2020

Management of acute colonic pseudo-obstruction

1 reference

12 December 2020

Clostridium difficile in inflammatory bowel disease relapse

1 reference

12 December 2020

Treatment of recurrent antibiotic-associated pseudomembranous colitis.

1 reference

12 December 2020

Ascites associated with antibiotic-associated pseudomembranous colitis.

1 reference

12 December 2020

Clostridium difficile and its cytotoxin in hospitalized children with acute diarrhea

1 reference

12 December 2020

Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India

1 reference

12 December 2020

Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: a 5 year retrospective study

1 reference

12 December 2020

Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children.

1 reference

12 December 2020

Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile

1 reference

12 December 2020

Clostridium difficile-associated diarrhea and colitis

1 reference

12 December 2020

Massive mural edema in severe pseudomembranous colitis.

1 reference

12 December 2020

10.1007/S12664-011-0148-Y

Identifiers

DOI

1 reference

26 August 2017

1 reference